메뉴 건너뛰기




Volumn 24, Issue 34, 2006, Pages 5403-5407

Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIRUBICIN; ANTINEOPLASTIC AGENT;

EID: 34247161758     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.05.8065     Document Type: Article
Times cited : (43)

References (32)
  • 1
    • 17644427902 scopus 로고    scopus 로고
    • American Cancer Society:, Atlanta, GA, American Cancer Society
    • American Cancer Society: Cancer Facts and Figures 2006. Atlanta, GA, American Cancer Society, 2006
    • (2006) Cancer Facts and Figures 2006
  • 2
    • 0027917369 scopus 로고
    • Clinical trials in testicular cancer
    • Einhorn LH: Clinical trials in testicular cancer. Cancer 71:3182-3184, 1993
    • (1993) Cancer , vol.71 , pp. 3182-3184
    • Einhorn, L.H.1
  • 3
    • 0027462641 scopus 로고
    • Surgical salvage of chemotherapy refractory germ cell tumors
    • Murphy B, Breeden ES, Donohue JP, et al: Surgical salvage of chemotherapy refractory germ cell tumors. J Clin Oncol 11:324-329, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 324-329
    • Murphy, B.1    Breeden, E.S.2    Donohue, J.P.3
  • 4
    • 0023695848 scopus 로고
    • Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide
    • Loehrer PJ Sr, Lauer R, Roth BJ, et al: Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109:540-546, 1988
    • (1988) Ann Intern Med , vol.109 , pp. 540-546
    • Loehrer Sr, P.J.1    Lauer, R.2    Roth, B.J.3
  • 5
    • 0344734200 scopus 로고    scopus 로고
    • Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor
    • Loehrer PJ Sr, Gonin R, Nichols CR, et al: Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16:2500-2504, 1998
    • (1998) J Clin Oncol , vol.16 , pp. 2500-2504
    • Loehrer Sr, P.J.1    Gonin, R.2    Nichols, C.R.3
  • 6
    • 27244441799 scopus 로고    scopus 로고
    • Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors
    • Kondagunta GV, Bacik J, Donadio A, et al: Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23:6549-6555, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 6549-6555
    • Kondagunta, G.V.1    Bacik, J.2    Donadio, A.3
  • 7
    • 0034306291 scopus 로고    scopus 로고
    • High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer
    • Bhatia S, Abonour R, Porcu P, et al: High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 18:3346-3352, 2000
    • (2000) J Clin Oncol , vol.18 , pp. 3346-3352
    • Bhatia, S.1    Abonour, R.2    Porcu, P.3
  • 8
    • 0036534301 scopus 로고    scopus 로고
    • A phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group
    • Hinton S, Catalano P, Einhorn LH, et al: A phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): A trial of the Eastern Cooperative Oncology Group. J Clin Oncol 20:1859-1863, 2002
    • (2002) J Clin Oncol , vol.20 , pp. 1859-1863
    • Hinton, S.1    Catalano, P.2    Einhorn, L.H.3
  • 9
    • 0028200671 scopus 로고
    • Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: The Indiana University experience
    • Saxman SB, Nichols CR, Einhorn LH: Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: The Indiana University experience. J Clin Oncol 12:1390-1393, 1994
    • (1994) J Clin Oncol , vol.12 , pp. 1390-1393
    • Saxman, S.B.1    Nichols, C.R.2    Einhorn, L.H.3
  • 10
    • 0035868955 scopus 로고    scopus 로고
    • Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results or an international multicenter analysis
    • Hartmann JT, Einhorn L, Nichols CR, et al: Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results or an international multicenter analysis. J Clin Oncol 19:1641-1648, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 1641-1648
    • Hartmann, J.T.1    Einhorn, L.2    Nichols, C.R.3
  • 11
    • 0031041148 scopus 로고    scopus 로고
    • Late relapse of germ cell tumors after cisplatin-based chemotherapy
    • Gerl A, Clemm C, Schmeller N, et al: Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 8:41-47, 1997
    • (1997) Ann Oncol , vol.8 , pp. 41-47
    • Gerl, A.1    Clemm, C.2    Schmeller, N.3
  • 12
    • 0029003920 scopus 로고
    • Late relapse of testicular cancer
    • Baniel J, Foster RS, Gonin R, et al: Late relapse of testicular cancer. J Clin Oncol 13:1170-1176, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 1170-1176
    • Baniel, J.1    Foster, R.S.2    Gonin, R.3
  • 13
    • 27244438586 scopus 로고    scopus 로고
    • Incidence of late-relapse germ cell tumor and outcome to salvage therapy
    • Ronnen EA, Kondagunta GV, Bacik J, et al: Incidence of late-relapse germ cell tumor and outcome to salvage therapy. J Clin Oncol 23:6999-7004, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 6999-7004
    • Ronnen, E.A.1    Kondagunta, G.V.2    Bacik, J.3
  • 14
    • 0034018538 scopus 로고    scopus 로고
    • Results of treatment after relapse from high-dose chemotherapy in germ cell tumors
    • Porcu P, Bahtia S, Sharma M, et al: Results of treatment after relapse from high-dose chemotherapy in germ cell tumors. J Clin Oncol 18:1181-1186, 2000
    • (2000) J Clin Oncol , vol.18 , pp. 1181-1186
    • Porcu, P.1    Bahtia, S.2    Sharma, M.3
  • 15
    • 0025141586 scopus 로고
    • A phase II study of daily oral etoposide in refractory germ cell tumors
    • Miller JC, Einhorn LH: A phase II study of daily oral etoposide in refractory germ cell tumors. Semin Oncol 17:36-39, 1990
    • (1990) Semin Oncol , vol.17 , pp. 36-39
    • Miller, J.C.1    Einhorn, L.H.2
  • 16
    • 0015380003 scopus 로고
    • Clinical use of adriamycin in advanced testicular cancer
    • Monfardini S, Bajetta E, Musumeci R, et al: Clinical use of adriamycin in advanced testicular cancer. J Urol 108:293-296, 1972
    • (1972) J Urol , vol.108 , pp. 293-296
    • Monfardini, S.1    Bajetta, E.2    Musumeci, R.3
  • 17
    • 0017328320 scopus 로고
    • Improved chemotherapy in disseminated testicular cancer
    • Einhorn LH, Donohue JP: Improved chemotherapy in disseminated testicular cancer. J Urol 117:65-69, 1977
    • (1977) J Urol , vol.117 , pp. 65-69
    • Einhorn, L.H.1    Donohue, J.P.2
  • 18
    • 0017653469 scopus 로고
    • Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer
    • Higby DJ, Wallace HJ, Henderson ES, et al: Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer. Cancer Treat Rep 61:869-873, 1977
    • (1977) Cancer Treat Rep , vol.61 , pp. 869-873
    • Higby, D.J.1    Wallace, H.J.2    Henderson, E.S.3
  • 19
    • 0017073635 scopus 로고
    • Combination chemotherapy with adriamycin and cis-diamminedichloroplatinum in patients with neoplastic diseases
    • Vogl SE, Ohnuma T, Perloff M, et al: Combination chemotherapy with adriamycin and cis-diamminedichloroplatinum in patients with neoplastic diseases. Cancer 38:21-26, 1976
    • (1976) Cancer , vol.38 , pp. 21-26
    • Vogl, S.E.1    Ohnuma, T.2    Perloff, M.3
  • 20
    • 0019494152 scopus 로고
    • The role of maintenance therapy in disseminated testicular cancer
    • Einhorn LH, Williams SD, Troner M, et al: The role of maintenance therapy in disseminated testicular cancer. N Engl J Med 305:727-731, 1981
    • (1981) N Engl J Med , vol.305 , pp. 727-731
    • Einhorn, L.H.1    Williams, S.D.2    Troner, M.3
  • 21
    • 0021016115 scopus 로고
    • Chemotherapy of refractory germ cell cancer with etoposide
    • Lederman GS, Garnick MB, Canellos GP, et al: Chemotherapy of refractory germ cell cancer with etoposide. J Clin Oncol 11:706-709, 1983
    • (1983) J Clin Oncol , vol.11 , pp. 706-709
    • Lederman, G.S.1    Garnick, M.B.2    Canellos, G.P.3
  • 22
    • 0026751953 scopus 로고
    • High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: A phase II study
    • Stoter G, Akdas A, Fossa SD, et al: High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: A phase II study. Ann Oncol 3:577-578, 1992
    • (1992) Ann Oncol , vol.3 , pp. 577-578
    • Stoter, G.1    Akdas, A.2    Fossa, S.D.3
  • 23
    • 84871470235 scopus 로고
    • A phase II trial of epirubicin (EPI) in the salvage therapy of germ cell tumours
    • abstr 388
    • Schultz SM, Loehrer P, Williams S, et al: A phase II trial of epirubicin (EPI) in the salvage therapy of germ cell tumours. Proc Am Soc Clin Oncol 6:99, 1987 (abstr 388)
    • (1987) Proc Am Soc Clin Oncol , vol.6 , pp. 99
    • Schultz, S.M.1    Loehrer, P.2    Williams, S.3
  • 24
    • 12644293443 scopus 로고
    • Phase II trial with single agent epirubicin (EPI) as salvage chemotherapy (CT) in refractory germ cell tumours (RGCT)
    • abstr 563
    • Lecesne A, Droz JP, Azab M, et al: Phase II trial with single agent epirubicin (EPI) as salvage chemotherapy (CT) in refractory germ cell tumours (RGCT). Proc Am Soc Clin Oncol 9:145, 1990 (abstr 563)
    • (1990) Proc Am Soc Clin Oncol , vol.9 , pp. 145
    • Lecesne, A.1    Droz, J.P.2    Azab, M.3
  • 25
    • 0025035342 scopus 로고
    • High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II study
    • Harstrick A, Schmoll HJ, Wilke H, et al: High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: A phase II study. Ann Oncol 1:375-376, 1990
    • (1990) Ann Oncol , vol.1 , pp. 375-376
    • Harstrick, A.1    Schmoll, H.J.2    Wilke, H.3
  • 26
    • 0036231815 scopus 로고    scopus 로고
    • A 20% dose reduction of the original CISCAA/B regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: Final results of a phase III randomized trial
    • Fizazi K, Do KA, Wang X, el al: A 20% dose reduction of the original CISCAA/B regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: Final results of a phase III randomized trial. Ann Oncol 113:125-134, 2002
    • (2002) Ann Oncol , vol.113 , pp. 125-134
    • Fizazi, K.1    Do, K.A.2    Wang, X.3    el al4
  • 27
    • 0030052587 scopus 로고    scopus 로고
    • Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
    • Bokemeyer C, Beyer J, Metzner B, et al: Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Ann Oncol 7:31-34, 1996
    • (1996) Ann Oncol , vol.7 , pp. 31-34
    • Bokemeyer, C.1    Beyer, J.2    Metzner, B.3
  • 28
    • 0032055188 scopus 로고    scopus 로고
    • A phase II trial of paclitaxel in refractory germ cell tumors
    • Sandler AB, Cnstou A, Fox S, et al: A phase II trial of paclitaxel in refractory germ cell tumors. Cancer 82:1381-1386, 1998
    • (1998) Cancer , vol.82 , pp. 1381-1386
    • Sandler, A.B.1    Cnstou, A.2    Fox, S.3
  • 29
    • 0033015208 scopus 로고    scopus 로고
    • Phase II trial of gemcitabine in refractory germ cell tumors
    • Einhorn LH, Stender MJ, Williams SD, et al: Phase II trial of gemcitabine in refractory germ cell tumors. J Clin Oncol 17:509-511, 1999
    • (1999) J Clin Oncol , vol.17 , pp. 509-511
    • Einhorn, L.H.1    Stender, M.J.2    Williams, S.D.3
  • 30
    • 0033044108 scopus 로고    scopus 로고
    • Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer
    • Bokemeyer C, Gerl A, Schoffski P, et al: Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer. J Clin Oncol 17:512-516, 1999
    • (1999) J Clin Oncol , vol.17 , pp. 512-516
    • Bokemeyer, C.1    Gerl, A.2    Schoffski, P.3
  • 31
    • 0037089634 scopus 로고    scopus 로고
    • Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: A study of the German Testicular Cancer Study Group
    • Kollmannsberger C, Rick O, Dengs HG, et al: Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: A study of the German Testicular Cancer Study Group. J Clin Oncol 20:2031-2037, 2002
    • (2002) J Clin Oncol , vol.20 , pp. 2031-2037
    • Kollmannsberger, C.1    Rick, O.2    Dengs, H.G.3
  • 32
    • 3142577828 scopus 로고    scopus 로고
    • Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group
    • Kollmannsberger C, Beyer J, Liersch R, et al: Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group. J Clin Oncol 22:108-114, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 108-114
    • Kollmannsberger, C.1    Beyer, J.2    Liersch, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.